TABRECTA

Identification of Tabrecta

No description

Google image searchProduct monograph

Active ingredient

capmatinib (capmatinib hydrochloride), 150 MG

DIN: 02527391

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 16-SEP-2022

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
• L01EX17 — CAPMATINIB (ATC/DDD)

External Links for Tabrecta

Search on Google

• Tabrecta side effects
• Tabrecta dosage
• capmatinib side effects
• capmatinib dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find tabrecta photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.